|
TMEM185B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.059930E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.49929999998722E-06 |
| Normal-vs-Stage2 |
6.171000E-01 |
| Normal-vs-Stage3 |
1.059240E-01 |
| Normal-vs-Stage4 |
1.965200E-01 |
| Stage1-vs-Stage2 |
2.466500E-02 |
| Stage1-vs-Stage3 |
3.203900E-03 |
| Stage1-vs-Stage4 |
3.615600E-02 |
| Stage2-vs-Stage3 |
8.674000E-02 |
| Stage2-vs-Stage4 |
1.557190E-01 |
| Stage3-vs-Stage4 |
8.376600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.439600E-03 |
| Normal-vs-AfricanAmerican |
6.393900E-02 |
| Normal-vs-Asian |
4.595800E-01 |
| Caucasian-vs-AfricanAmerican |
9.393600E-01 |
| Caucasian-vs-Asian |
2.935800E-01 |
| AfricanAmerican-vs-Asian |
3.026600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.0545000000437E-06 |
| Normal-vs-Female |
4.336300E-02 |
| Male-vs-Female |
5.11650000034614E-07 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.037600E-01 |
| Normal-vs-Extreme_Weight |
3.0135999995462E-07 |
| Normal-vs-Obese |
6.050600E-01 |
| Normal-vs-Extreme_Obese |
1.603680E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.265000E-03 |
| Normal_Weight-vs-Obese |
9.364800E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.655430E-01 |
| Extreme_Weight-vs-Obese |
6.164200E-03 |
| Extreme_Weight-vs-Extreme_Obese |
4.292400E-01 |
| Obese-vs-Extreme_Obese |
1.720370E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.698300E-02 |
| Normal-vs-Age(41-60Yrs) |
1.095430E-01 |
| Normal-vs-Age(61-80Yrs) |
2.02599999999942E-05 |
| Normal-vs-Age(81-100Yrs) |
1.407810E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.814480E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.319100E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.141800E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.527700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.369540E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.118400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.11909999991988E-07 |
| Normal-VS-Type2 PRCC |
6.265600E-01 |
| Normal-VS-KIRP CIMP |
1.543120E-03 |
| Normal-VS-Unclassified PRCC |
8.036400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.06269999999798E-05 |
| Type1 PRCC-VS-KIRP CIMP |
3.759600E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
4.809500E-04 |
| Type2 PRCC-VS-KIRP CIMP |
1.396190E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
5.692800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.604710E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.500700E-03 |
| Normal-vs-N1 |
7.978700E-03 |
| Normal-vs-N2 |
3.265000E-01 |
| N0-vs-N1 |
7.009500E-04 |
| N0-vs-N2 |
1.958590E-01 |
| N1-vs-N2 |
8.665600E-01 |
|
|
